VIMAB Group AB (publ) (NM4) Stock Price & News

All values in SEK	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	93.03M	86.58M	67.45M	90.88M
Cost of goods sold	72.25M	82.41M	64.31M	70.01M
Cost of revenue	72.25M	82.41M	64.31M	70.01M
Research and development expenses	-	-	-	-
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	19.57M	22.10M	18.67M	20.52M
Operating expense	25.26M	53.58M	22.30M	24.52M
Total operating expenses	97.51M	135.99M	86.62M	94.53M
Operating income	-4.47M	-49.42M	-19.17M	-3.65M
Other non operating income	745.00K	-8.65M	815.00K	1.28M
EBT including unusual items	-5.03M	-55.09M	-21.85M	-3.19M
EBT excluding unusual items	-5.03M	-62.34M	-21.85M	-8.24M
Income tax expense	-	-505.00K	-	-
Effective tax rate	-	0.92%	-	-
Other operating expenses	-500.00K	8.74M	-2.03M	-1.52M
Net income	-5.03M	-54.58M	-21.85M	-3.19M
Net profit margin	-5.41%	-63.05%	-32.39%	-3.51%
Earnings per share	-	-	-	-
Interest and investment income	-	39.00K	-	-
Interest expense	-1.31M	-4.59M	-3.50M	-5.87M
Net interest expenses	-1.31M	-4.55M	-3.50M	-5.87M
Depreciation and amortization charges	6.19M	22.74M	5.67M	5.53M
EBITDA	1.71M	-39.01M	-13.50M	1.88M
Gain or loss from assets sale	-	13.11M	-	-

Ask anything